Please wait while we load the requested 10-K report or click the link below:
Integra LifeSciences Reports Fourth Quarter and Full Year 2015 Financial Results and Issues 2016 Full Year Guidance
Fourth Quarter Revenues Increased 10.1% to $241.2 Million
Fourth Quarter Adjusted EPS of $0.87; Reported EPS of $0.39
Full Year Organic Revenues Increased 6.7%
Fourth quarter revenue increased 10.1% over the prior year quarter to $241.2 million;
Organic revenues increased 3.9% in the fourth quarter and 6.7% for the full year;
Adjusted net income increased 7.2% over the prior year quarter to $32.8 million;
Full year 2015 cash flow from operations was $106.7 million, an increase of $47.8 million over the prior year, with adjusted free cash flow conversion of 67.5% compared to 22.3% in 2014; and,
2016 full year guidance includes organic growth of approximately 7% and double digit adjusted EPS growth.
The following information was filed by Integra Lifesciences Holdings Corp (IART) on Thursday, February 25, 2016 as an 8K 2.02 statement, which is an earnings press release pertaining to results of operations and financial condition. It may be helpful to assess the quality of management by comparing the information in the press release to the information in the accompanying 10-K Annual Report statement of earnings and operation as management may choose to highlight particular information in the press release.
View differences made from one year to another to evaluate Integra Lifesciences Holdings Corp's financial trajectory
Compare this 10-K Annual Report to its predecessor by reading our highlights to see what text and tables were
removed , and by Integra Lifesciences Holdings Corp.